INS and gestational diabetes: Additionally, meta-analyses of risks and benefits of using insulin, metformin and glyburide in GDM women requiring drug treatment have shown that glyburide is inferior to both insulin and metformin, resulting in higher birth weights and increased risk of macrosomia, while metformin is associated with more preterm births than insulin [54].